The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?

One of the most common tumors in the world is hepatocellular carcinoma (HCC), and its mortality rates are still on the rise, so addressing it is considered an important challenge for universal health. Despite the various treatments that have been developed over the past decades, the prognosis for ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganjalikhani Hakemi, Mazdak, Jafarinia, Morteza, Azizi, Mahdieh, Rezaeepoor, Mahsa, Isayev, Orkhan, Bazhin, Alexandr V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793963/
https://www.ncbi.nlm.nih.gov/pubmed/33425759
http://dx.doi.org/10.3389/fonc.2020.601661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793963/
https://www.ncbi.nlm.nih.gov/pubmed/33425759
http://dx.doi.org/10.3389/fonc.2020.601661

Ejemplares similares